C12N 9/1205
Phosphotransferases with an alcohol group as acceptor
Official title: {Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases}
C12N9/1205 (Phosphotransferases with an alcohol group as acceptor) appears on 2,229 US grants and 3,013 published applications in this corpus.
Search patents in C12N- Granted patents
- 2,229
- Published applications
- 3,013
- Assignees
- 1,223
- Inventors
- 6,084
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 11 | 0 |
| 1997 | 26 | 0 |
| 1998 | 78 | 0 |
| 1999 | 108 | 0 |
| 2000 | 93 | 0 |
| 2001 | 123 | 26 |
| 2002 | 114 | 220 |
| 2003 | 115 | 276 |
| 2004 | 127 | 225 |
| 2005 | 86 | 199 |
| 2006 | 93 | 136 |
| 2007 | 99 | 134 |
| 2008 | 91 | 125 |
| 2009 | 68 | 128 |
| 2010 | 82 | 125 |
| 2011 | 60 | 102 |
| 2012 | 71 | 103 |
| 2013 | 71 | 93 |
| 2014 | 84 | 90 |
| 2015 | 56 | 75 |
| 2016 | 59 | 67 |
| 2017 | 49 | 83 |
| 2018 | 56 | 68 |
| 2019 | 50 | 93 |
| 2020 | 53 | 86 |
| 2021 | 58 | 90 |
| 2022 | 51 | 99 |
| 2023 | 50 | 89 |
| 2024 | 42 | 114 |
| 2025 | 52 | 97 |
| 2026 | 38 | 70 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method of producing allolactose6 Oct 2026US 12,753,425 B2Chr. Hansen A/S
- Immune cells with enhanced cytotoxicity and methods of use thereof29 Sep 2026US 12,747,443 B2Ludwig Institute for Cancer Research
- Genetic engineering of fungi to modulate tryptamine expression22 Sep 2026US 12,742,160 B2Empyrean Neuroscience, Inc.
- Methods and compositions for chimeric antigen receptor targeting cancer cells1 Sep 2026US 12,721,892 B2The University of North Carolina at Chapel Hill
- Cancer combination therapies utilizing a nicotinamide phosphoribosyltransferase inhibitor in combination with a nicotinamide adenine dinucleotide salvage pathway precursor25 Aug 2026US 12,714,722 B2Fred Hutchinson Cancer Center
- Novel biosynthesis system for producing 3'-phosphoadenosine-5'-phosphosulfate and application thereof8 Oct 2026US 2026/0308651 A1Jiangnan University
- Fructokinase variant and method for producing l-amino acid using same24 Sep 2026US 2026/0286320 A1Cj Cheiljedang Corporation
- High-yield fructosylated chondroitin-producing Escherichia coli and its application thereof24 Sep 2026US 2026/0286412 A1Jiangnan University
- Targeted lnp compositions for in vivo immune cell engineering and methods of use thereof17 Sep 2026US 2026/0274918 A1CREATE Medicines, Inc.
- Enzymatic conversion of d-xylose into d-ribose and d-ribulose-5-phosphate17 Sep 2026US 2026/0275395 A1Kookmin University Industry Academy Cooperation Foundation
Most cited
By later US patents
- Isozyme-specific activators of protein kinase C methods and compositions146US 6,165,977 AThe Board of Trustees of the Leland Stanford Junior University · 2000
- Inhibitors of human phosphatidyl-inositol 3-kinase delta138US 6,949,535 B2ICOS Corporation · 2005
- Inhibitors of human phosphatidylinositol 3-kinase delta135US 6,667,300 B2ICOS Corporation · 2003
- Redirection of cellular immunity by receptor chimeras135US 7,049,136 B2The General Hospital Corporation · 2006
- Lipid kinase133US 5,858,753 AICOS Corporation · 1999